Foundry Partners, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$5,127,437
+7.0%
481,902
+5.8%
0.31%
+4.0%
Q1 2023$4,790,966
+89668.9%
455,415
+5.7%
0.30%
+2.7%
Q4 2022$5,337
-99.9%
430,775
+21.3%
0.29%
+26.7%
Q3 2022$3,678,000
+0.5%
355,050
+11.9%
0.23%
+5.5%
Q2 2022$3,658,000
+11.9%
317,226
+22.0%
0.22%
+31.7%
Q1 2022$3,270,000
-66.1%
259,943
-68.6%
0.17%
-51.2%
Q4 2021$9,651,000
-17.3%
827,733
-7.3%
0.34%
-18.4%
Q3 2021$11,663,000893,0700.42%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders